
STRO P/E Ratio
P/E Ratio as of Jul 2, 2025: -0.26
Average-0.2733
Median-0.2700
Minimum-0.3100
Maximum-0.2300
-0.26
Past Month+0.04 (13.33%)
The P/E ratio for STRO is -0.26 as of Jul 2, 2025. This represents a decrease of -78.15% compared to its 12-month average P/E ratio of -1.19. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Sutro Biopharma Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Sutro Biopharma Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Sutro Biopharma Inc to industry peers.
Sutro Biopharma Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Sutro Biopharma Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Sutro Biopharma Inc to industry peers.
STRO P/E Ratio Insights
See Sutro Biopharma Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in STRO
Order type
Buy in
Order amount
Est. shares
0 shares
STRO P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $0.68 | -0.23 |
Jun 2, 2025 | $0.9048 | -0.30 |
May 1, 2025 | $1.07 | -0.36 |
Apr 1, 2025 | $0.5953 | -0.20 |
Mar 3, 2025 | $1.435 | -0.88 |
Feb 3, 2025 | $1.90 | -1.17 |
Jan 2, 2025 | $1.93 | -1.19 |
STRO End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.26 | -76.99% |
2024 | -1.13 | -23.13% |
2023 | -1.47 | -52.88% |
2022 | -3.12 | -52.07% |
2021 | -6.51 | -72.05% |
2020 | -23.29 | — |
FAQs About Sutro Biopharma Inc (STRO) P/E ratio
The latest P/E ratio of STRO is -0.26, as of Jul 2, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Sutro Biopharma Inc’s last 12-month average P/E ratio is -1.19, compared to its current P/E ratio of -0.26. This reflects a decrease of -78.15%.
Sutro Biopharma Inc’s current P/E ratio of -0.26 is lower than its last 12-month average P/E of -1.19. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Sutro Biopharma Inc’s average P/E ratio over the last 3 years is -1.83. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Sutro Biopharma Inc’s average P/E ratio over the last 5 years is -12.47. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.